ResMed RMD Sleep And Breathing Health — Selling, general, and administrative
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's sleep and breathing health — selling, general, and administrative.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ResMed's sleep and breathing health — selling, general, and administrative?
- ResMed (RMD) reported sleep and breathing health — selling, general, and administrative of $149.51M in Q1 2026.
- How has ResMed's sleep and breathing health — selling, general, and administrative changed year-over-year?
- ResMed's sleep and breathing health — selling, general, and administrative increased by 23.0% year-over-year, from $121.56M to $149.51M.
- What is the long-term trend for ResMed's sleep and breathing health — selling, general, and administrative?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — selling, general, and administrative has grown at a 5.3% compound annual growth rate (CAGR), from $443.47M to $491.59M.
- What does sleep and breathing health — selling, general, and administrative mean?
- Captures the indirect operating expenses required to support the Sleep and Breathing Health segment, including sales force compensation, marketing, and administrative overhead. These costs reflect the investment in market penetration and operational infrastructure for the segment. Monitoring this helps evaluate the scalability of the business model.